A retinal implant that can restore vision degraded by age has been approved for use in Europe and could soon be available in the U.S. So much to seeThe PRIMA retinal implant, created by the Science Corporation, can “restore functional central vision” in those with geographic atrophy (an advanced form of macular degeneration), said Stanford Medicine . “Normal vision in the U.S. is 20/20, and blindness is 20/200,” Frank Brodie, the medical director for vision and the PRIMA implant at the Science Corporation, said to New Scientist . “We have a cochlear implant for vision now,” Max Hodak, the founder and CEO of Science Corporation, said to Stat News. Science Corporation and “its medical partners in Europe are currently in discussion with healthcare providers over reimbursement.”